Quintiles Chief Medical and Scientific Officer Dr. Jeffrey Spaeder will testify before an FDA hearing on Monday, February 4, 2013, to share Quintiles’ support of a proposed pathway to speed the introduction of new therapies to patients with life-threatening illnesses and for patients with unmet medical needs.

The formal subject of the FDA hearing is: "Creating an Alternative Approval Pathway for Certain Drugs Intended to Address Unmet Medical Need."

Dr. Spaeder’s testimony can be accessed in PDF format here on Quintiles.com.

Live Webcast

The FDA will provide live access to the hearing through a webcast beginning at 9:00 a.m. EST at https://collaboration.fda.gov/altapprovefeb2013